Prokidney (PROK) Tax Provisions (2021 - 2025)
Prokidney's (PROK) quarterly Tax Provisions came in at -$33.8 million in Q4 2025, down 2083.02% year-over-year from $1.7 million in Q4 2024, and down 6126.96% quarter-over-quarter from $560000.0 in Q3 2025.
Analysis
Prokidney (PROK) Tax Provisions (2021 - 2025) Analysis & Trends
Prokidney (PROK) has reported Tax Provisions for 5 consecutive years, with -$33.8 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Tax Provisions fell 2083.02% year-over-year to -$33.8 million in Q4 2025; TTM through Jun 2026 was -$33.2 million, a 4254.07% decrease from a year earlier, with the FY2025 full-year figure at -$31.8 million, down 5209.7% from the prior year.
- Tax Provisions was -$33.8 million for Q4 2025 at Prokidney, down from $560000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $2.8 million in Q4 2023 and troughed at -$33.8 million in Q4 2025.
- A 5-year average of -$1.4 million and a median of $575500.0 in 2025 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 1614.29% in 2025, down 2083.02% in 2025.
- Over 5 years, Tax Provisions stood at $114000.0 in 2021, then tumbled by 1207.02% to -$1.3 million in 2022, then surged by 321.16% to $2.8 million in 2023, then slumped by 39.02% to $1.7 million in 2024, then tumbled by 2083.02% to -$33.8 million in 2025.
- The last three Tax Provisions figures came in at -$33.8 million (Q4 2025), $560000.0 (Q3 2025), and $848000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 11.31 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 1.00 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | -1.40 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -22.30 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 1.84 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 3.14 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | - |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -33.75 Mn |
| Sep 30, 2025 | 560,000.00 |
| Jun 30, 2025 | 848,000.00 |
| Mar 31, 2025 | 591,000.00 |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | -2.34 Mn |
| Jun 30, 2024 | -56,000.00 |
| Mar 31, 2024 | 98,000.00 |
| Dec 31, 2023 | 2.79 Mn |
| Sep 30, 2023 | 913,000.00 |
| Jun 30, 2023 | 965,000.00 |
| Mar 31, 2023 | 1.33 Mn |
| Dec 31, 2022 | -1.26 Mn |
| Sep 30, 2022 | -75,000.00 |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | 1.01 Mn |
| Dec 31, 2021 | 114,000.00 |
| Sep 30, 2021 | -60,000.00 |